CGX-1007

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCGX-1007
Drug Alias NameConantokin GConotoxin G VCGX-1007ConG
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlutamate [NMDA] receptor subunit epsilon 2 antagonists
TargetsGlutamate [NMDA] receptor subunit epsilon 2
Therapy Area/IndicationsNerve DegenerationEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPrecipio
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedtronicCognetixPrecipio
Active IndicationsN/A
Inactive IndicationsNerve DegenerationEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A